NATUREX : Half-year summary of the liquidity contract

Press release

Avignon, January 5, 2018

Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of December 31, 2017, negotiation date:

• 4,899 NATUREX shares


• 604,069.00 euros

It is reminded that the following assets appeared on the liquidity account as of June 30, 2017, negotiation date:

• 2,626 NATUREX shares


• 783,958.00 euros

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr

• Financial schedule

  
  
  - Revenue - FY 2017
  6 February 2018
  
  
  - 2017 annual results
  28 March 2018
  
  
   



• Upcoming events

  
  
  - Analysts meeting (SFAF - French Society of Financial Analysts), Paris
  29 March 2018
  
  
  - AGM
  21 June 2018
  
  
  

Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.

The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.

Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2016 had revenue of €404.4 million.

The Group is listed on Euronext Paris, Compartment B – Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY

NATUREX, From Nature to You

> Contact investors / financial media

Carole Alexandre

Head of Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]

Source: Actusnews